(Q54367099)
Statements
Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia (English)
Ardeshir Ghavamzadeh
Kamran Alimoghaddam
Shahrbano Rostami
Mohamad Jahani
Massoud Iravani
Seyed Asadollah Mousavi